GeneDx Holdings (WGS) Debt to Equity (2020 - 2025)
Historic Debt to Equity for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $0.18.
- GeneDx Holdings' Debt to Equity fell 3063.91% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year decrease of 3063.91%. This contributed to the annual value of $0.21 for FY2024, which is 839.32% down from last year.
- Latest data reveals that GeneDx Holdings reported Debt to Equity of $0.18 as of Q3 2025, which was down 3063.91% from $0.19 recorded in Q2 2025.
- Over the past 5 years, GeneDx Holdings' Debt to Equity peaked at $0.27 during Q2 2024, and registered a low of -$0.04 during Q1 2021.
- Moreover, its 5-year median value for Debt to Equity was $0.04 (2022), whereas its average is $0.1.
- Per our database at Business Quant, GeneDx Holdings' Debt to Equity soared by 117355.31% in 2024 and then plummeted by 3063.91% in 2025.
- Quarter analysis of 5 years shows GeneDx Holdings' Debt to Equity stood at $0.04 in 2021, then increased by 10.53% to $0.04 in 2022, then soared by 495.59% to $0.23 in 2023, then fell by 8.39% to $0.21 in 2024, then decreased by 16.63% to $0.18 in 2025.
- Its last three reported values are $0.18 in Q3 2025, $0.19 for Q2 2025, and $0.2 during Q1 2025.